» Articles » PMID: 36183490

Antibody Response to COVID-19 Vaccines Among Workers with a Wide Range of Exposure to Per- and Polyfluoroalkyl Substances

Overview
Journal Environ Int
Date 2022 Oct 2
PMID 36183490
Authors
Affiliations
Soon will be listed here.
Abstract

Per- and polyfluoroalkyl substances (PFAS) are a broad class of synthetic chemicals; some are present in most humans in developed countries. Several studies have shown associations between certain PFAS, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), and reduced antibody concentration after vaccination against diseases such as Tetanus. Recent studies have reported associations between COVID-19 occurrence and exposure to certain types of PFAS. However, studies of antibody concentration after COVID-19 vaccination in relation to PFAS serum concentrations have not been reported. We examined COVID-19 antibody responses to vaccines and PFAS serum concentrations among employees and retirees from two 3M facilities, one of which historically manufactured PFOS, PFOA, and perfluorohexane sulfonic acid (PFHxS). Participants completed enrollment and follow-up study visits in the Spring of 2021, when vaccines were widely available. In total 415 participants with 757 observations were included in repeated measures analyses. Log-transformed concentrations of anti-spike IgG and neutralizing antibodies were modeled in relation to concentration of PFAS at enrollment after adjusting for antigenic stimulus group (9 groups determined by COVID-19 history and number and type of vaccination) and other variables. The fully adjusted IgG concentration was 3.45 percent lower (95% CI -7.03, 0.26) per 14.5 ng/mL (interquartile range) increase in PFOS; results for neutralizing antibody and PFOS were similar. For PFOA, PFHxS, and perfluorononanoic acid (PFNA), the results were comparable to those for PFOS, though of smaller magnitude. In our study data, the fully adjusted coefficients relating concentration of vaccine-induced antibodies to COVID-19 and interquartile range difference in serum concentration of PFOS, PFOA, PFHxS, and PFNA were inverse but small with confidence intervals that included zero. Our analysis showed that the coefficient for the four PFAS examined in detail was considerably affected by adjustment for antigenic stimulus group.

Citing Articles

Exposure to Pollutants and Vaccines' Effectiveness: A Systematic Review.

Protano C, Valeriani F, Vitale K, Del Prete J, Liguori F, Liguori G Vaccines (Basel). 2024; 12(11).

PMID: 39591155 PMC: 11599004. DOI: 10.3390/vaccines12111252.


Fish consumption benefits and PFAS risks: Epidemiology and public health recommendations.

Hamade A Toxicol Rep. 2024; 13:101736.

PMID: 39391711 PMC: 11465044. DOI: 10.1016/j.toxrep.2024.101736.


County-level associations between drinking water PFAS contamination and COVID-19 mortality in the United States.

Liddie J, Bind M, Karra M, Sunderland E J Expo Sci Environ Epidemiol. 2024; .

PMID: 39369072 DOI: 10.1038/s41370-024-00723-5.


Effects of Perfluorohexane Sulfonate Exposure on Immune Cell Populations in Naive Mice.

Pierpont T, Elmore J, Redko A, Anannya O, Imbiakha B, OHare K Immunohorizons. 2024; 8(8):538-549.

PMID: 39109956 PMC: 11374752. DOI: 10.4049/immunohorizons.2300049.


There's Something in What We Eat: An Overview on the Extraction Techniques and Chromatographic Analysis for PFAS Identification in Agri-Food Products.

Iannone A, Carriera F, Passarella S, Fratianni A, Avino P Foods. 2024; 13(7).

PMID: 38611389 PMC: 11011820. DOI: 10.3390/foods13071085.


References
1.
Callow K . Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg (Lond). 1985; 95(1):173-89. PMC: 2129501. DOI: 10.1017/s0022172400062410. View

2.
Ng K, Faulkner N, Cornish G, Rosa A, Harvey R, Hussain S . Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020; 370(6522):1339-1343. PMC: 7857411. DOI: 10.1126/science.abe1107. View

3.
Olsen G, Logan P, Hansen K, Simpson C, Burris J, Burlew M . An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. AIHA J (Fairfax, Va). 2003; 64(5):651-9. DOI: 10.1202/375.1. View

4.
Schisterman E, Cole S, Platt R . Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20(4):488-95. PMC: 2744485. DOI: 10.1097/EDE.0b013e3181a819a1. View

5.
De Silva A, Armitage J, Bruton T, Dassuncao C, Heiger-Bernays W, Hu X . PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding. Environ Toxicol Chem. 2020; 40(3):631-657. PMC: 7906948. DOI: 10.1002/etc.4935. View